Search research articles
Contact Us
Filters
Showing results (71-80 of 301) with videos related to
Page
of 31
Sort By:
Psychiatric Services (Washington, D.C.)
|
April 27, 2000
The cost of access to mental health services in managed care
E Weissman, K Pettigrew, S Sotsky, et al.
Nucleic Acids Research
|
November 11, 1990
Herpesvirus saimiri U RNA sequence variation
J J Trimble, D A Regier, R C Desrosiers
BMJ Global Health
|
October 17, 2024
Qualitative genomic research with Indigenous peoples: a scoping review of participatory practice
Morgan Ehman, Nadine R Caron, Laurie Montour, et al.
Journal of Health Economics
|
April 7, 2009
Bayesian and classical estimation of mixed logit: An application to genetic testing
Dean A Regier, Mandy Ryan, Euan Phimister, et al.
BMC Health Services Research
|
January 27, 2021
Describing practices of priority setting and resource allocation in publicly funded health care systems of high-income countries
Brayan V Seixas, Dean A Regier, Stirling Bryan, et al.
Cancer
|
September 24, 2019
Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug Review
Adam J N Raymakers, Dean A Regier, Stuart J Peacock
Journal of Cancer Survivorship : Research and Practice
|
September 30, 2022
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping review
Steve E Kalloger, Cheryl Ho, Craig Mitton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Dean A Regier, Nick Bansback, Anne Dar Santos, et al.
Current Oncology (Toronto, Ont.)
|
June 2, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care
Adam J N Raymakers, David Cameron, Scott Tyldesley, et al.
BMC Cancer
|
October 14, 2020
Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin's lymphoma: a probabilistic analysis
A J N Raymakers, S Costa, D Cameron, et al.
Page
of 31
Search research articles
Search
Showing results (71-80 of 301) with videos related to
Sort By:
Page
of 31
Psychiatric Services (Washington, D.C.)
|
April 27, 2000
The cost of access to mental health services in managed care
E Weissman, K Pettigrew, S Sotsky, et al.
Nucleic Acids Research
|
November 11, 1990
Herpesvirus saimiri U RNA sequence variation
J J Trimble, D A Regier, R C Desrosiers
BMJ Global Health
|
October 17, 2024
Qualitative genomic research with Indigenous peoples: a scoping review of participatory practice
Morgan Ehman, Nadine R Caron, Laurie Montour, et al.
Journal of Health Economics
|
April 7, 2009
Bayesian and classical estimation of mixed logit: An application to genetic testing
Dean A Regier, Mandy Ryan, Euan Phimister, et al.
BMC Health Services Research
|
January 27, 2021
Describing practices of priority setting and resource allocation in publicly funded health care systems of high-income countries
Brayan V Seixas, Dean A Regier, Stirling Bryan, et al.
Cancer
|
September 24, 2019
Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug Review
Adam J N Raymakers, Dean A Regier, Stuart J Peacock
Journal of Cancer Survivorship : Research and Practice
|
September 30, 2022
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping review
Steve E Kalloger, Cheryl Ho, Craig Mitton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Dean A Regier, Nick Bansback, Anne Dar Santos, et al.
Current Oncology (Toronto, Ont.)
|
June 2, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care
Adam J N Raymakers, David Cameron, Scott Tyldesley, et al.
BMC Cancer
|
October 14, 2020
Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin's lymphoma: a probabilistic analysis
A J N Raymakers, S Costa, D Cameron, et al.
Page
of 31